Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2016 |
Mar. 31, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
Dec. 31, 2014 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Mar. 31, 2015 |
|
| Sales | $ 18,283 | $ 0 | $ 182,474 | $ 0 | |||||
| Cost of Sales | 12,019 | 0 | 70,894 | 0 | |||||
| Gross Margin | 6,264 | 0 | 111,580 | 0 | |||||
| Operating expenses | |||||||||
| Sales and marketing | 187,265 | 0 | 269,463 | 0 | |||||
| Research and development | 813,773 | $ 343,742 | 768,301 | 1,231,563 | 1,378,123 | $ 1,101,820 | $ 1,397,554 | $ 1,489,483 | $ 1,537,491 |
| General and administrative | 577,853 | 1,438,553 | 372,342 | 1,881,467 | 874,443 | 1,192,244 | 3,676,125 | 2,666,669 | 1,621,341 |
| Share-based compensation expense | 204,842 | 158,244 | 26,724 | 424,090 | 1,324,282 | 112,573 | 1,495,837 | 1,709,230 | 484,210 |
| Depreciation | 23,590 | 14,387 | 15,478 | 33,753 | 32,480 | 34,036 | 63,454 | 59,479 | 44,448 |
| Total operating expenses | 1,807,323 | 1,954,926 | 1,182,845 | 3,840,336 | 3,609,328 | 2,440,673 | 6,632,970 | 5,924,861 | 3,687,490 |
| Other expenses (income) | |||||||||
| Imputed interest expense | 0 | 27,677 | 0 | 0 | 27,677 | ||||
| Interest expense | (5,203) | 0 | 0 | 10,031 | 0 | 6,212 | 2,839 | 3,018 | 6,391 |
| Other income | (395,296) | (8,522) | (5,533) | (406,514) | (23,012) | (46,026) | (42,173) | (33,974) | (46,349) |
| Foreign exchange loss | (71,399) | 36,211 | 112,771 | 184,125 | 36,211 | ||||
| Change in fair value of warrant derivative liability | (2,130,106) | (870,913) | (3,496,070) | (1,739,047) | (4,413,819) | 0 | (7,742,555) | (484,124) | 6,387,473 |
| Total other expenses (income) | (2,530,605) | (950,834) | (3,501,603) | (2,135,530) | (4,436,831) | 24,074 | (7,669,118) | (330,955) | 6,411,403 |
| Net (loss) income for the period | (1,004,092) | (1,593,226) | 827,503 | (2,464,747) | 1,036,148 | (5,593,906) | (10,098,893) | ||
| Foreign exchange translation adjustment | 0 | (24,390) | 0 | 24,799 | 409 | ||||
| Net income (loss) and comprehensive income (loss) for the period | $ 729,546 | $ (1,004,092) | $ 2,318,758 | $ (1,593,226) | $ 827,503 | $ (2,489,137) | $ 1,036,148 | $ (5,569,107) | $ (10,098,484) |
| Income (loss) per share - basic (in dollars per share) | $ 0.01 | $ (0.01) | $ 0.03 | $ (0.02) | $ 0.01 | $ (0.05) | $ 0.01 | $ (0.08) | $ (0.20) |
| Income (loss) per share - diluted (in dollars per share) | $ 0.01 | $ (0.01) | $ (0.02) | $ (0.02) | $ (0.05) | $ (0.05) | $ (0.08) | $ (0.08) | $ (0.20) |
| Weighted average number of shares outstanding - basic (in shares) | 85,924,462 | 72,455,753 | 72,408,313 | 87,232,426 | 61,491,674 | 48,225,034 | 71,554,822 | 67,210,266 | 50,226,548 |
| Weighted average number of shares outstanding - diluted (in shares) | 89,789,461 | 72,455,753 | 76,270,355 | 87,232,426 | 69,508,395 | 48,225,034 | 79,984,257 | 67,210,266 | 50,226,548 |